PTSM: Pharmaceutical Technology Sourcing and Management-12-03-2014

New practical approaches to the synthesis of complex heterocycles are reviewed.

European CDMOs want into the US market, but limited options leave them on the outside, looking in.

Enterprise quality management systems can help shift the quality emphasis from corrective to preventive actions.

Manufacturers face regulatory overhaul, while brand-generic debates escalate over biosimilars and labeling changes.

The authors take a look at some of the recent developments in the German pharmaceutical market.

Tufts research suggests costs to launch a new drug have doubled since 2003, but some question conclusions.